We are live on ! Find out more
TCM

Traynor Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 62.36%
This Fund
S&P 500
This Quarter Est. Return
+5.92%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.66%
AUM
$210M
AUM Growth
+$7.69M
Cap. Flow
+$4.27M
Cap. Flow %
2.03%
Top 10 Hldgs %
44.48%
Holding
178
New
16
Increased
72
Reduced
69
Closed
10

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$840K
2
AAPL icon
Apple
AAPL
+$728K
3
MO icon
Altria Group
MO
+$501K
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$439K
5
SNAP icon
Snap
SNAP
+$408K

Top Sells

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$516K
2
AMZN icon
Amazon
AMZN
+$363K
3
QCOM icon
Qualcomm
QCOM
+$343K
4
VMC icon
Vulcan Materials
VMC
+$287K
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$239K

Sector Composition

Rank Sector Weight
1 Technology 11.78%
2 Communication Services 11.14%
3 Healthcare 9.45%
4 Consumer Discretionary 7.27%
5 Industrials 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WPRT
176
Westport Fuel Systems
WPRT
$33.5M
– –
-1,000
Closed -$16K
ORIG
177
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
– –
-2
Closed -$4K
BDSI
178
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-20,000
Closed -$69K
4 5 6 7
8

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.17B AUM 11.2% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
MMLI
Massachusetts Mutual Life Insurance Springfield, Massachusetts $2.17B AUM 48.68% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM

Traynor Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Traynor Capital Management held 178 positions worth $210M, up 3.8% from $203M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Traynor Capital Management's Q3 2017 filing shows 16 new, 72 increased, 69 reduced and 10 closed positions. Its largest new stake was Teva Pharmaceuticals: 19,502 shares worth $335K. The largest sale was Alnylam Pharmaceuticals, an estimated $516K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Communication Services and Healthcare.

  • Traynor Capital Management's largest Q3 2017 buy was Teva Pharmaceuticals: 19,502 shares worth $335K.
  • Traynor Capital Management added most to Intuitive Surgical in Q3 2017, an estimated $840K increase.
  • Traynor Capital Management's biggest Q3 2017 reduction was Amazon, cutting an estimated $363K.
  • Traynor Capital Management fully exited Alnylam Pharmaceuticals in Q3 2017, selling an estimated $516K.
  • Traynor Capital Management's ten largest holdings make up 44% of its $210M portfolio in Q3 2017.
  • Traynor Capital Management opened 16 new positions and closed 10 in Q3 2017.
  • Traynor Capital Management's portfolio value rose 3.8% quarter-over-quarter to $210M.

Based on Traynor Capital Management's 13F filing for Q3 2017, filed 27 Oct 2017.